ArticleBone reports2022

Intravenous Zoledronate 4 mg for the treatment of post-menopausal osteoporosis: A prospective open-labeled study.

Thunyawarin Arunthanachaikul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.